PharmaceuticalART Recherches et Technologies Avancées Inc. , entreprise canadienne d'appareils médicaux et chef de file en développement de produits d'imagerie optique moléculaire destinés aux industries des soins de la santé et pharmaceutique, annonce qu'Ã...
52 hours ago
ART Advanced Research Technologies Inc. , a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announces that its strategic review process has culminated in ART ...
52 hours ago
ART Advanced Research Technologies Inc. , a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announces that its strategic review process has culminated in ART ...
52 hours ago
Ironwood Pharmaceuticals, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of shares of its Class A common stock. The ...
53 hours ago
Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration has approved the supplemental New Drug Application for ABILIFY for the treatment of irritability associated with autistic ...
53 hours ago
Vertex Pharmaceuticals Incorporated today announced that it will webcast its presentations at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, December 2, 2009 at 2:00 p.m. EST and at the 2009 Deutsche Bank Biotech Boston Confab ...
55 hours ago
Medications are important for managing the signs and symptoms of lupus, a serious and potentially life-threatening autoimmune disease that affects an estimated 1.5 million Americans. To educate people with lupus about the need to adhere to their ...
56 hours ago
Polo Biology Global Group Corporation Board Appointments
56 hours ago
The Down Syndrome Research and Treatment Foundation announces the identification of a new potential therapeutic strategy to address cognitive decline and improve cognition in Down syndrome. The findings were published in Science Translational ...
56 hours ago
The New York Society of Security Analysts will present the 13th Annual Biotech and Specialty Pharmaceuticals Conference on December 1, 2009.
57 hours ago
Lannett Company, Inc. today announced that its Board of Directors has approved a reauthorization of the stock repurchase program. Under the program, the company is authorized to repurchase up to $5 million of Lannett's outstanding common stock from ...
57 hours ago
The Board of Directors of Omnicare, Inc. , a leading provider of pharmaceutical care for the elderly, declared today a quarterly cash dividend of 2.25 cents per share on its common stock. The dividend is payable December 21, 2009 to stockholders of ...
58 hours ago
Pfizer today announced that the U.S. Food and Drug Administration has approved Geodon Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating ...
59 hours ago
PharMerica Corporation , a national provider of institutional pharmacy and hospital pharmacy management services, announced that it has appointed Geoffrey G. Meyers to the Company's Board of Directors.
60 hours ago
Research and Markets has announced the addition of the 'Nigeria Pharmaceuticals and Healthcare Report Q1 2010' report to their offering.
61 hours ago
|
|
